+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Ocular Inflammation"

Ophthalmic Medical Lasers Global Market Report 2024 - Product Thumbnail Image

Ophthalmic Medical Lasers Global Market Report 2024

  • Report
  • November 2023
  • 250 Pages
  • Global
From
Uveitis Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Uveitis Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • February 2024
  • 204 Pages
  • Global
From
From
From
  • 8 Results (Page 1 of 1)
Loading Indicator

Ocular inflammation is a condition that affects the eyes and can cause a variety of symptoms, including redness, pain, and blurred vision. It is often caused by infection, allergies, or injury, and can be treated with topical medications, such as corticosteroids, antibiotics, and anti-inflammatory drugs. In the optical market, ocular inflammation is a major concern, as it can lead to vision loss and other complications. Treatment options are available to reduce the symptoms and prevent further damage. In the optical market, there are a number of companies that specialize in ocular inflammation treatments. These include Allergan, Bausch + Lomb, Novartis, and Santen Pharmaceuticals. These companies offer a range of products, from eye drops and ointments to oral medications and injections. Additionally, many of these companies are involved in research and development of new treatments for ocular inflammation. Show Less Read more